Democratic governors in three states have announced that their states will be stockpiling abortion pills after a far right federal judge issued a sweeping ruling on Friday aimed at taking mifepristone — a drug used for abortions and management of Cushing’s syndrome — off the shelves nationwide.
On Monday, California Gov. Gavin Newsom (D) announced that the state has negotiated a contract to obtain 2 million pills of misoprostol, a drug typically used in combination with mifepristone to induce a miscarriage, but which can also be used on its own for abortions. Newsom said that the move is aimed at even further protecting abortion access in the state, which has positioned itself as an abortion haven.
“In response to this extremist ban on a medication abortion drug, our state has secured a stockpile of an alternative medication abortion drug to ensure that Californians continue to have access to safe reproductive health treatments,” Newsom said in a statement. “We will not cave to extremists who are trying to outlaw these critical abortion services. Medication abortion remains legal in California.”
While the governor’s office acknowledged in a press release that the combination of the two drugs is slightly more effective and free of side effects than a misoprostol-only abortion, it does not say if the state is planning to stockpile mifepristone, the drug that could potentially be removed as a result of Friday’s ruling.
There is no imminent threat of a broad ban of misoprostol, though far right District Judge Matthew Kascmaryk’s ruling opens the door for future attacks on all Food and Drug Administration (FDA) approved drugs, as Slate’s Mark Joseph Stern has noted.
Massachusetts and Washington are also planning to stockpile abortion drugs, though they are buying doses of mifepristone. Washington Gov. Jay Inslee (D) announced last week that the state already purchased 30,000 doses of mifepristone in anticipation of the ruling, which the state received in late March. The stockpile is enough to last Washington three years.
Meanwhile, also on Monday, Massachusetts Gov. Maura Healey (D) announced that her state is purchasing about 15,000 doses of mifepristone, enough to last about a year. Healey, a former Massachusetts attorney general, pledged that her state would resist efforts to outlaw the drug.
“I know the odds in this case,” she said. “I know the legal landscape, which is why what this judge [in Texas] did is a sham and I am not the least bit concerned about [legal] liability.”
Mifepristone is currently still available in states where abortion is legal. The drug is also used for purposes other than abortion, like cervical ripening for insertion of certain types of birth control, and has been shown time and again to be safe when used in combination with misoprostol for abortions.
The future of the drug is currently unclear. Legal analysts have said that there is essentially no legal thrust behind Kascmaryk’s reasoning in ruling that the FDA was wrong to approve the drug in 2000, pointing out, for instance, that the statute of limitations to challenge the approval ended 17 years ago. Almost immediately after Kascmaryk’s ruling, a Washington judge ordered authorities not to restrict access to the drug, setting the stage for a conflict that will almost certainly reach the Supreme Court.
Democrats have been urging the FDA to ignore Kascmaryk’s ruling entirely, and have said that the decision is a show of the corruption embedded in the U.S.’s judicial system.
We’re not backing down in the face of Trump’s threats.
As Donald Trump is inaugurated a second time, independent media organizations are faced with urgent mandates: Tell the truth more loudly than ever before. Do that work even as our standard modes of distribution (such as social media platforms) are being manipulated and curtailed by forces of fascist repression and ruthless capitalism. Do that work even as journalism and journalists face targeted attacks, including from the government itself. And do that work in community, never forgetting that we’re not shouting into a faceless void – we’re reaching out to real people amid a life-threatening political climate.
Our task is formidable, and it requires us to ground ourselves in our principles, remind ourselves of our utility, dig in and commit.
As a dizzying number of corporate news organizations – either through need or greed – rush to implement new ways to further monetize their content, and others acquiesce to Trump’s wishes, now is a time for movement media-makers to double down on community-first models.
At Truthout, we are reaffirming our commitments on this front: We won’t run ads or have a paywall because we believe that everyone should have access to information, and that access should exist without barriers and free of distractions from craven corporate interests. We recognize the implications for democracy when information-seekers click a link only to find the article trapped behind a paywall or buried on a page with dozens of invasive ads. The laws of capitalism dictate an unending increase in monetization, and much of the media simply follows those laws. Truthout and many of our peers are dedicating ourselves to following other paths – a commitment which feels vital in a moment when corporations are evermore overtly embedded in government.
Over 80 percent of Truthout‘s funding comes from small individual donations from our community of readers, and the remaining 20 percent comes from a handful of social justice-oriented foundations. Over a third of our total budget is supported by recurring monthly donors, many of whom give because they want to help us keep Truthout barrier-free for everyone.
You can help by giving today. Whether you can make a small monthly donation or a larger gift, Truthout only works with your support.